Fate Therapeutics
FATE
#6708
Rank
C$0.59 B
Marketcap
$5.25
Share price
-3.25%
Change (1 day)
73.19%
Change (1 year)

EPS for Fate Therapeutics (FATE)

EPS in 2023 (TTM): -$2.94

According to Fate Therapeutics 's latest financial reports the company's current EPS (TTM) is -$2.94. In 2022 the company made an earnings per share (EPS) of -$3.95 a decrease over its 2021 EPS that were of -$3.02.

EPS history for Fate Therapeutics from 2013 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$2.94-25.42%
2022-$3.9530.49%
2021-$3.027.21%
2020-$2.8245.45%
2019-$1.9419.17%
2018-$1.6317.65%
2017-$1.38-3.77%
2016-$1.44-12.4%
2015-$1.64-3.97%
2014-$1.71-2.09%
2013-$1.75

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-$10.62 260.83%๐Ÿ‡บ๐Ÿ‡ธ USA
$7.53-355.76%๐Ÿ‡บ๐Ÿ‡ธ USA
-$11.73 298.62%๐Ÿ‡บ๐Ÿ‡ธ USA
-$4.20 42.86%๐Ÿ‡บ๐Ÿ‡ธ USA
$2.66-190.32%๐Ÿ‡บ๐Ÿ‡ธ USA